Publications by authors named "Leonard Meltzer"

Claim this Profile
S
Synthesis and in vivo evaluation of 3,4-disubstituted gababutins.
David C Blakemore, Justin S Bryans, Pauline Carnell, Mark J Field, Natasha Kinsella, Leonard T Meltzer

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine effects in animal models of psychosis and cognitive function.
Hugh M Marston, Jared W Young, Frederic D C Martin, Kevin A Serpa, Christopher L Moore, Leonard T Meltzer

Psychopharmacology (Berl)· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.
Bazoumana Ouattara, Samah Belkhir, Marc Morissette, Mehdi Dridi, Pershia Samadi, Leonard T Meltzer

J Mol Neurosci· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of tolylamine 5-HT6 antagonists.
Jamie M Singer, Michael W Wilson, Paul D Johnson, Shelley R Graham, Leonard W Cooke, Leonard T Meltzer

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Pershia Samadi, Laurent Grégoire, Marc Morissette, Fréderic Calon, Abdallah Hadj Tahar, Leonard T Meltzer

Neurobiol Aging· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys.
Pershia Samadi, Marc Morissette, Fréderic Calon, Abdallah Hadj Tahar, Mehdi Dridi, Leonard T Meltzer

Synapse· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Marc Morissette, Mehdi Dridi, Frédéric Calon, Abdallah Hadj Tahar, Leonard T Meltzer

Synapse· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Marc Morissette, Mehdi Dridi, Frédéric Calon, Abdallah Hadj Tahar, Leonard T Meltzer

Mov Disord· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.
Thomas R Belliotti, Thomas Capiris, I Victor Ekhato, Jack J Kinsora, Mark J Field, Leonard T Meltzer

J Med Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
Pierre J Blanchet, Frédéric Calon, Marc Morissette, Abdallah Hadj Tahar, Nancy Bélanger, Leonard Meltzer

Parkinsonism Relat Disord· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues.
Brian E Kornberg, Sham S Nikam, Jon L Wright, Suzanne R Kesten, Leonard T Meltzer

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
Abdallah Hadj Tahar, Laurent Grégoire, Aurélie Darré, Nancy Bélanger, Leonard Meltzer

Neurobiol Dis· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one: synthesis and pharmacological activity.
Bastiaan J Venhuis, Durk Dijkstra, David J Wustrow, Leonard T Meltzer, Lawrence D Wise

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NR2B selective NMDA receptor antagonists.
Sham S Nikam, Leonard T Meltzer

Curr Pharm Des· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.
Bastiaan J Venhuis, Nienke Rodenhuis, Håkan V Wikström, David Wustrow, Leonard T Meltzer

J Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis